Most of the recurrently mutated genes identified have previously been reported to harbor pathogenic SNVs and indels in CBF AML (Supplementary Table 3), e.g., ASXL2, KIT, KRAS, and ZBTB7A [8, 10]. This evidence concerns the gene CEBPZ and acute myeloid leukemia.